Karl Deisseroth
InvestorProfessor of Bioengineering and Psychiatry, Stanford at Red Tree Venture
Stanford
About
Karl Deisseroth is the D.H. Chen Professor of Bioengineering and Psychiatry at Stanford and an HHMI Investigator. He holds an undergraduate degree from Harvard and both a PhD and MD from Stanford, is board-certified by the American Board of Psychiatry and Neurology, and founded and directs the Stanford Human Neural Circuitry program. His work spans natural light-gated ion channels and how brain properties emerge from cellular activity, and he authored the nonfiction book Projections. He serves on Red Tree Venture Capital's Scientific Advisory Board.
Invests in
BiotechDigital Health
Colleagues at Red Tree Venture
Adam Silverman
Red Tree Venture Labs Biologics at Red Tree Venture
Antonio Lepore
Senior Associate at Red Tree Venture
Ariell Ortega
Executive Assistant at Red Tree Venture
Bill Robinson
Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Brian Stearns
Red Tree Venture Labs Chemistry at Red Tree Venture
Cassie Lue
VP of Investor Relations at Red Tree Venture
Crystal Mackall
Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
Deborah Nguyen
Red Tree Venture Labs Operating Partner at Red Tree Venture